TIBER CREEK GROUP

Lobbying for EMD SERONO, INC. · Biopharmaceuticals.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income · posted Apr 18, 2026

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to reproductive healthcare and IVF.

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.